Engineering Venom’s Toxin-Neutralizing Antibody Fragments and Its Therapeutic Potential
Clicks: 458
ID: 273331
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
77.9
/100
458 views
306 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #11 of 148 articles by views in Toxins
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 148 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Serum therapy remains the only specific treatment against envenoming, but anti-venoms are still prepared by fragmentation of polyclonal antibodies isolated from hyper-immunized horse serum. Most of these anti-venoms are considered to be efficient, but their production is tedious, and their use may be associated with adverse effects. Recombinant antibodies and smaller functional units are now emerging as credible alternatives and constitute a source of still unexploited biomolecules capable of neutralizing venoms. This review will be a walk through the technologies that have recently been applied leading to novel antibody formats with better properties in terms of homogeneity, specific activity and possible safety.
| Reference Key |
alvarenga2014toxinsengineering
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Larissa M. Alvarenga;Muhammad Zahid;Anne Di Tommaso;Matthieu O. Juste;Nicolas Aubrey;Philippe Billiald;Julien Muzard;Alvarenga, Larissa M.;Zahid, Muhammad;Tommaso, Anne Di;Juste, Matthieu O.;Aubrey, Nicolas;Billiald, Philippe;Muzard, Julien; |
| Journal | Toxins |
| Year | 2014 |
| DOI |
10.3390/toxins6082541
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.